Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients | GenomeWeb

By Adam Bonislawski

A research team led by Yale University has completed a multi-center, 1,500-subject study evaluating the use of the protein biomarkers urine interleuken 18, urine neutrophil gelatinase-associated lipocalin, and plasma NGAL as a way to predict acute kidney injury in patients undergoing cardiac surgery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.